Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 84, Issue 1, 2003, Pages 77-86

  Abi Farah, C ^a   Nguyen, M D ^b,c   Julien, J P ^b   Leclerc, Nicole ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Axon; Dendrites; Microtubule associated proteins; Microtubules; Phosphorylation

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 2; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; DISEASE COURSE; MOLECULAR RECOGNITION; MOUSE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSPORT KINETICS;

ACTINS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BINDING, COMPETITIVE; CYTOSKELETON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFILAMENT PROTEINS; SPINAL CORD; SUPEROXIDE DISMUTASE; TISSUE DISTRIBUTION; TUBULIN;

ANIMALIA;

EID: 0037262120     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01505.x     Document Type: Article

References (52)

1. Arias C., Arrieta I., Massieu L. and Tapia R. (1997) Neuronal damage and MAP2 changes induced by the glutamate transport inhibitor dihydrokainate and by kainate in rat hippocampus in vivo. Exp. Brain Res. 116, 467-476.
2. Black M. M., Keyser P. and Sobel E. (1986) Interval between the synthesis and assembly of cytoskeletal proteins in cultured neurons. J. Neurosci. 6, 1004-1012.
3. Bruijn L. I., Becher M. W., Lee M. K., Anderson K. L., Jenkins N. A., Copeland N. G., Sisodia S. S., Rothstein J. D., Borchelt D. R., Price D. L. and Cleveland D. W. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338.
4. Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S. D., Ohama E., Reaume A. G., Scott R. W. and Cleveland D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851-1854.
5. Buee L., Bussiere T, Buee-Scherrer V., Delacourte A. and Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130.
6. Cudkowicz M. E., McKenna-Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., Schoenfeld D. A., Hosler B. A., Horvitz H. R. and Brown R. H. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41, 210-221.
7. Davare M. A., Dong F., Rubin C. S. and Hell J. W. (1999) The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C 1-type calcium channels in neurons. J. Biol. Chem. 274, 30280-30287.
8. Dhavan R. and Tsai L. H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
9. Ekinci F. J. and Shea T. B. (1999) Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC. Brain Res. 850, 207-216.
10. Fischer I., Romano-Clarke G. and Grynspan F. (1991) Calpain-mediated proteolysis of microtubule associated proteins MAP1B and MAP2 in developing brain. Neurochem. Res. 16, 891-898.
11. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T. and Hirokawa N. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488-491.
12. Harada A., Teng J., Takei Y., Oguchi K. and Hirokawa N. (2002) MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J. Cell Biol. 158, 541-549.
13. Hirano A., Nakano I., Kurland L. T., Mulder D. W., Holley P. W. and Saccomanno G. (1984) Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 471-480.
14. Hoshi M., Akiyama T., Shinohara Y., Miyata Y., Ogawara H., Nishida E. and Sakai H. (1988) Protein-kinase-C-catalyzed phosphorylation of the microtubule-binding domain of microtubule-associated protein 2 inhibits its ability to induce tubulin polymerization. Eur. J. Biochem. 174, 225-230.
15. Irving E. A., McCulloch J. and Dewar D. (1996) Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Acta Neuropathol. 92, 186-196.
16. Jancsik V., Filliol D., Felter S. and Rendon A. (1989) Binding of microtubule-associated proteins (MAPs) to rat brain mitochondria: a comparative study of the binding of MAP2, its microtubule-binding and projection domains, and tau proteins. Cell Motil. Cytoskeleton 14, 372-381.
17. Johnson G. V., Jope R. S. and Binder L. I. (1989) Proteolysis of tau by calpain. Biochem Biophys. Res. Commun. 163, 1505-1511.
18. Julien J. P. (2001) Amyotrophic lateral sclerosis, unfolding the toxicity of the misfolded. Cell 104, 581-591.
19. Jung D., Filliol D., Miehe M. and Rendon A. (1993) Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU. Cell Motil. Cytoskeleton 24, 245-255.
20. Kiernan J. A. and Hudson A. J. (1993) Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain 116, 203-215.
21. Kikuchi H., Doh-ura K., Kawashima T., Kira J. and Iwaki T (1999) Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule-associated protein 2 (MAP2) antibodies. Acta Neuropathol. 97, 13-21.
22. 2+ and protein kinase C. Trends Pharmacol. Sci. 17, 114-120.
23. Lanius R. A., Paddon H. B., Mezei M., Wagey R., Krieger C., Pelech S. L. and Shaw C. A. (1995) A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J. Neurochem. 65, 927-930.
24. Li M., Ona V. O., Guegan C., Chen M., Jackson-Lewis V., Andrews L. J., Olszewski A. J., Stieg P. E., Lee J. P., Przedborski S. and Friedlander R. M. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335-339.
25. Lim R. W. and Halpain S. (2000) Regulated association of microtubule-associated protein 2 (MAP2) with Src and Grb2: evidence for MAP2 as a scaffolding protein. J. Biol. Chem. 275, 20578-20587.
26. Linden M., Nelson B. D. and Leterrier J. F. (1989) The specific binding of the microtubule-associated protein 2 (MAP2) to the outer membrane of rat brain mitochondria. Biochem. J. 261, 167-173.
27. Litersky J. M. and Johnson G. V. (1995) Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. J. Neurochem. 65, 903-911.
28. Maas T., Eidenmuller J. and Brandt R. (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J. Biol. Chem. 275, 15733-15740.
29. Micheva K. D., Vallee A., Beaulieu C., Herman I. M. and Leclerc N. (1998) β-Actin is confined to structures having high capacity of remodelling in developing and adult rat cerebellum. Eur J. Neurosci. 10, 3785-3798.
30. Minger S. L., Geddes J. W., Holtz M. L., Craddock S. D., Whiteheart S. W., Siman R. G. and Pettigrew L. C. (1998) Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res. 810, 181-199.
31. Nguyen M. D., Lariviere R. C. and Julien J. P. (2000) Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc. Natl Acad. Sci. USA 97, 12306-12311.
32. Nguyen M. D., Lariviere R. C. and Julien J. P. (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
33. Ozer R. S. and Halpain S. (2000) Phosphorylation-dependent localization of microtubule-associated protein MAP2c to the actin cytoskeleton. Mol. Biol. Cell 11, 3573-3587.
34. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P. and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
35. Posmantur R. M., Kampfl A., Taft W. C., Bhattacharjee M., Dixon C. E., Bao J. and Hayes R. L. (1996) Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J. Neurotrauma 13, 125-137.
36. Pramatarova A., Laganiere J., Roussel J., Brisebois K. and Rouleau G. A. (2001) Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374.
37. Riederer B. M. (1992) Differential phosphorylation of some proteins of the neuronal cytoskeleton during brain development. Histochem. J. 24, 783-790.
38. Riederer B. M., Draberova E., Viklicky V. and Draber P. (1995) Changes of MAP2 phosphorylation during brain development. J. Histochem. Cytochem. 43, 1269-1284.
39. Rosen D. R. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362.
40. Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J. and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
41. Rouleau G. A., Clark A. W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J. P. and Figlewicz D. (1996) SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39, 128-131.
42. Saito K., Elce J. S., Hamos J. E. and Nixon R. A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl Acad. Sci. USA 90, 2628-2632.
43. Sanchez C., Diaz-Nido J. and Avila J. (2000) Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog. Neurobiol. 61, 133-168.
44. Trieu V. N., Liu R., Liu X. P. and Uckun F. M. (2000) A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 267, 22-25.
45. Trotti D., Rolfs A., Danbolt N. C., Brown R. H. Jr and Hediger M. A. (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 427-433.
46. Wada Y., Ishiguro K., Itoh T. J., Uchida T., Hotani H., Saito T., Kishimoto T. and Hisanaga S. (1998) Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity. J. Biochem. 124, 738-746.
47. Wagey R. T. and Krieger C. (1998) Abnormalities of protein kinases in neurodegenerative diseases. Prog. Drug Res. 51, 133-183.
48. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
49. Williamson T. L. and Cleveland D. W. (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50-56.
50. Wong N. K., He B. P. and Strong M. J. (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59, 972-982.
51. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W. and Price D. L. (1995) An adverse property of a familial ALS-linked SODI mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
52. Zhu Q., Lindenbaum M., Levavasseur F., Jacomy H. and Julien J. P. (1998) Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin β,β′-iminodipropionitrile. J. Cell Biol. 143, 183-193.